176 related articles for article (PubMed ID: 18180381)
1. The effects of dasatinib on IgE receptor-dependent activation and histamine release in human basophils.
Kneidinger M; Schmidt U; Rix U; Gleixner KV; Vales A; Baumgartner C; Lupinek C; Weghofer M; Bennett KL; Herrmann H; Schebesta A; Thomas WR; Vrtala S; Valenta R; Lee FY; Ellmeier W; Superti-Furga G; Valent P
Blood; 2008 Mar; 111(6):3097-107. PubMed ID: 18180381
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of IgE-mediated secretion from human basophils with a highly selective Bruton's tyrosine kinase, Btk, inhibitor.
MacGlashan D; Honigberg LA; Smith A; Buggy J; Schroeder JT
Int Immunopharmacol; 2011 Apr; 11(4):475-9. PubMed ID: 21238622
[TBL] [Abstract][Full Text] [Related]
3. BTK inhibition is a potent approach to block IgE-mediated histamine release in human basophils.
Smiljkovic D; Blatt K; Stefanzl G; Dorofeeva Y; Skrabs C; Focke-Tejkl M; Sperr WR; Jaeger U; Valenta R; Valent P
Allergy; 2017 Nov; 72(11):1666-1676. PubMed ID: 28328081
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticosteroids rescue basophils from dasatinib-augmented immunoglobulin E-mediated histamine release.
Herrmann H; Blatt K; Ghanim V; Kneidinger M; Marth K; Valenta R; Valent P
Int Arch Allergy Immunol; 2012; 159(1):15-22. PubMed ID: 22555087
[TBL] [Abstract][Full Text] [Related]
5. The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib.
Hantschel O; Rix U; Schmidt U; Bürckstümmer T; Kneidinger M; Schütze G; Colinge J; Bennett KL; Ellmeier W; Valent P; Superti-Furga G
Proc Natl Acad Sci U S A; 2007 Aug; 104(33):13283-8. PubMed ID: 17684099
[TBL] [Abstract][Full Text] [Related]
6. FcepsilonRI-alpha siRNA inhibits the antigen-induced activation of mast cells.
Safaralizadeh R; Soheili ZS; Deezagi A; Pourpak Z; Samiei S; Moin M
Iran J Allergy Asthma Immunol; 2009 Dec; 8(4):177-83. PubMed ID: 20404387
[TBL] [Abstract][Full Text] [Related]
7. Reduced FcepsilonRI-mediated release of asthma-promoting cytokines and chemokines from human basophils during omalizumab therapy.
Oliver JM; Tarleton CA; Gilmartin L; Archibeque T; Qualls CR; Diehl L; Wilson BS; Schuyler M
Int Arch Allergy Immunol; 2010; 151(4):275-84. PubMed ID: 19844128
[TBL] [Abstract][Full Text] [Related]
8. Piceatannol is an effective inhibitor of IgE-mediated secretion from human basophils but is neither selective for this receptor nor acts on syk kinase at concentrations where mediator release inhibition occurs.
Miura K; Lavens-Phillips S; MacGlashan DW
Clin Exp Allergy; 2001 Nov; 31(11):1732-9. PubMed ID: 11696049
[TBL] [Abstract][Full Text] [Related]
9. Activation of Human Basophils by A549 Lung Epithelial Cells Reveals a Novel IgE-Dependent Response Independent of Allergen.
Schroeder JT; Bieneman AP
J Immunol; 2017 Aug; 199(3):855-865. PubMed ID: 28652400
[TBL] [Abstract][Full Text] [Related]
10. Multiple defects in Fc epsilon RI signaling in Syk-deficient nonreleaser basophils and IL-3-induced recovery of Syk expression and secretion.
Kepley CL; Youssef L; Andrews RP; Wilson BS; Oliver JM
J Immunol; 2000 Nov; 165(10):5913-20. PubMed ID: 11067953
[TBL] [Abstract][Full Text] [Related]
11. Sequential engagement of FcεRI on Mast Cells and Basophil Histamine H(4) Receptor and FcεRI in Allergic Rhinitis.
Shiraishi Y; Jia Y; Domenico J; Joetham A; Karasuyama H; Takeda K; Gelfand EW
J Immunol; 2013 Jan; 190(2):539-48. PubMed ID: 23241885
[TBL] [Abstract][Full Text] [Related]
12. IgE- and FcepsilonRI-mediated enhancement of surface CD69 expression in basophils: role of low-level stimulation.
Suzukawa M; Komiya A; Yoshimura-Uchiyama C; Kawakami A; Koketsu R; Nagase H; Iikura M; Yamada H; Ra C; Ohta K; Yamamoto K; Yamaguchi M
Int Arch Allergy Immunol; 2007; 143 Suppl 1():56-9. PubMed ID: 17541278
[TBL] [Abstract][Full Text] [Related]
13. Negative regulation of FcepsilonRI signaling by FcgammaRII costimulation in human blood basophils.
Kepley CL; Cambier JC; Morel PA; Lujan D; Ortega E; Wilson BS; Oliver JM
J Allergy Clin Immunol; 2000 Aug; 106(2):337-48. PubMed ID: 10932079
[TBL] [Abstract][Full Text] [Related]
14. SLP-76 is required for high-affinity IgE receptor- and IL-3 receptor-mediated activation of basophils.
Hidano S; Kitamura D; Kumar L; Geha RS; Goitsuka R
Int Immunol; 2012 Nov; 24(11):719-27. PubMed ID: 22875843
[TBL] [Abstract][Full Text] [Related]
15. A bispecific antibody against human IgE and human FcgammaRII that inhibits antigen-induced histamine release by human mast cells and basophils.
Tam SW; Demissie S; Thomas D; Daëron M
Allergy; 2004 Jul; 59(7):772-80. PubMed ID: 15180766
[TBL] [Abstract][Full Text] [Related]
16. Antigen-induced reduction in mast cell and basophil functional responses due to reduced Syk protein levels.
Kepley CL
Int Arch Allergy Immunol; 2005 Sep; 138(1):29-39. PubMed ID: 16088210
[TBL] [Abstract][Full Text] [Related]
17. Environmental polycyclic aromatic hydrocarbons, benzo(a) pyrene (BaP) and BaP-quinones, enhance IgE-mediated histamine release and IL-4 production in human basophils.
Kepley CL; Lauer FT; Oliver JM; Burchiel SW
Clin Immunol; 2003 Apr; 107(1):10-9. PubMed ID: 12738245
[TBL] [Abstract][Full Text] [Related]
18. IL-3 but not monomeric IgE regulates FcεRI levels and cell survival in primary human basophils.
Zellweger F; Buschor P; Hobi G; Brigger D; Dahinden CA; Villiger PM; Eggel A
Cell Death Dis; 2018 May; 9(5):510. PubMed ID: 29724998
[TBL] [Abstract][Full Text] [Related]
19. Redundant and opposing functions of two tyrosine kinases, Btk and Lyn, in mast cell activation.
Kawakami Y; Kitaura J; Satterthwaite AB; Kato RM; Asai K; Hartman SE; Maeda-Yamamoto M; Lowell CA; Rawlings DJ; Witte ON; Kawakami T
J Immunol; 2000 Aug; 165(3):1210-9. PubMed ID: 10903718
[TBL] [Abstract][Full Text] [Related]
20. Shikonin inhibits IgE-mediated histamine release by human basophils and Syk kinase activity.
Takano-Ohmuro H; Yoshida LS; Yuda Y; Morioka K; Kitani S
Inflamm Res; 2008 Oct; 57(10):484-8. PubMed ID: 18830561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
